Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1999-03-18 (27 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ILLKIRCH-GRAFFENSTADEN (67400), Bas-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA NIEDERBOURG SARL : revenue, balance sheet and financial ratios
PHARMACIE DE LA NIEDERBOURG SARL is a French company
founded 27 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ILLKIRCH-GRAFFENSTADEN (67400),
this company of category PME
shows in 2015 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA NIEDERBOURG SARL (SIREN 423103639)
Indicator
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
2 587 169 €
Net income
108 438 €
104 726 €
6 955 €
35 112 €
-57 165 €
59 363 €
79 335 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
104 593 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
3.1%
Revenue and income statement
In 2021, PHARMACIE DE LA NIEDERBOURG SARL generates positive net income of 108 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2021: 79 k€ -> 108 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
108 438 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 13%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
12.814%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
77.647%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA NIEDERBOURG SARL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
Debt ratio
1.655
6.949
19.947
18.014
16.354
14.489
12.814
Financial autonomy
88.012
82.544
75.459
75.67
76.721
77.752
77.647
Repayment capacity
0.36
None
None
None
None
None
None
Cash flow / Revenue
3.477%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
12.812021
2019
2020
2021
Q1: 29.03
Med: 85.54
Q3: 208.44
Excellent
In 2021, the debt ratio of PHARMACIE DE LA NIEDERBOU... (12.81) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
77.65%2021
2019
2020
2021
Q1: 25.88%
Med: 44.4%
Q3: 64.18%
Excellent
In 2021, the financial autonomy of PHARMACIE DE LA NIEDERBOU... (77.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 301.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
301.832
Liquidity indicators evolution PHARMACIE DE LA NIEDERBOURG SARL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
Liquidity ratio
370.427
304.331
278.803
284.717
303.885
322.58
301.832
Interest coverage
0.0
None
None
None
None
None
None
Sector positioning
Liquidity ratio
301.832021
2019
2020
2021
Q1: 139.19
Med: 190.69
Q3: 259.61
Excellent
In 2021, the liquidity ratio of PHARMACIE DE LA NIEDERBOU... (301.83) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 93 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 486 days. Excellent situation: suppliers finance 393 days of the operating cycle (retail model).
Operating WCR (2021)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2021)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
93 j
Supplier credit (2021)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
486 j
Inventory turnover (2021)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA NIEDERBOURG SARL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
Operating WCR
184 103 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
27
0
0
0
0
0
0
Customer payment term (days)
9
225
142
126
114
125
93
Supplier payment term (days)
23
450
409
435
456
428
486
Positioning of PHARMACIE DE LA NIEDERBOURG SARL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of PHARMACIE DE LA NIEDERBOURG SARL is estimated at
1 243 829 €
(range 799 788€ - 1 921 324€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
799k€1243k€1921k€
1 243 829 €Range: 799 788€ - 1 921 324€
NAF 5 année 2021
Valuation method used
Net Income Multiple
108 438 €
×
11.5x
=1 243 829 €
Range: 799 788€ - 1 921 325€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA NIEDERBOURG SARL with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA NIEDERBOURG SARL
What is the revenue of PHARMACIE DE LA NIEDERBOURG SARL ?
The revenue of PHARMACIE DE LA NIEDERBOURG SARL in 2015 is 2.6 M€.
Is PHARMACIE DE LA NIEDERBOURG SARL profitable?
Yes, PHARMACIE DE LA NIEDERBOURG SARL generated a net profit of 108 k€ in 2021.
Where is the headquarters of PHARMACIE DE LA NIEDERBOURG SARL ?
The headquarters of PHARMACIE DE LA NIEDERBOURG SARL is located in ILLKIRCH-GRAFFENSTADEN (67400), in the department Bas-Rhin.
Where to find the tax return of PHARMACIE DE LA NIEDERBOURG SARL ?
The tax return of PHARMACIE DE LA NIEDERBOURG SARL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA NIEDERBOURG SARL operate?
PHARMACIE DE LA NIEDERBOURG SARL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart